Biobanks contain sample specimens and associated sample and clinical information, often from many thousands of patients. They serve as valuable libraries for researchers, scientists, and clinicians, increasing the efficiency of patient recruitment into research studies. For this reason, biobanks are widely recognized for driving the development of many effective approaches to diagnose, treat, and cure disease. Never has the value of biobanks to medical research been more apparent than now, during the COVID-19 pandemic. With global efforts to curtail the spread of the disease advancing at a remarkable rate, biobanks hold vast promise for those seeking vaccines, treatments, and new testing modalities. However, COVID-19 workflows present many unique challenges that must be overcom

Join for free to read